135.5K XNAS Volume
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Kevin Hykes | Director, PRES & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 98,000 | 128,000 | - | 0 | Common Stock | |
| Kevin Hykes | Director, PRES & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 148,000 | 148,000 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 22,000 | 37,447 | - | 0 | Common Stock | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 33,000 | 33,000 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 16,000 | 16,835 | - | 0 | Common Stock | |
| Robert Allen John | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 55,000 | 55,000 | - | 0 | Common Stock | |
| Robert Allen John | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 38,000 | 38,000 | - | - | Stock Option (right to buy) | |
| Philip B. Adamson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Philip B. Adamson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 20,000 | 20,000 | - | 0 | Common Stock | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2024 | 2,500 | 73,306 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.14 per share. | 19 Nov 2024 | 2,500 | 3,305 | - | 5.1 | 12,853 | Common Stock |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 13.58 per share. | 19 Nov 2024 | 1,430 | 1,875 | - | 13.6 | 19,417 | Common Stock |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2024 | 1,040 | 835 | - | 0 | Common Stock | |
| Kevin J. Ballinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 36,136 | 36,136 | - | - | Stock Option (right to buy) | |
| Mitchell C. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 36,136 | 36,136 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Purchase of securities on an exchange or from another person at price $ 8.10 per share. | 15 Aug 2024 | 3,000 | 30,645 | - | 8.1 | 24,300 | Common Stock |
| Joseph P. Slattery | Director | Purchase of securities on an exchange or from another person at price $ 8.24 per share. | 08 Aug 2024 | 3,000 | 27,645 | - | 8.2 | 24,716 | Common Stock |
| Joseph P. Slattery | Director | Purchase of securities on an exchange or from another person at price $ 9.09 per share. | 06 Aug 2024 | 2,500 | 24,645 | - | 9.1 | 22,725 | Common Stock |
| Kevin Hykes | Director, PRES & CEO | Purchase of securities on an exchange or from another person at price $ 8.36 per share. | 05 Aug 2024 | 30,000 | 30,000 | - | 8.4 | 250,767 | Common Stock |
| Kevin Hykes | Director, PRES & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Robert Allen John | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 122,192 | 122,192 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| Mudit K. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| Kirk Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 20,961 | 20,961 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| Mudit K. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| Kirk Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 27,250 | 27,250 | - | - | Stock Option (right to buy) | |
| Craig E. Palmer | SVP, U.S. SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2024 | 379 | 0 | - | - | Stock Option (right to buy) | |
| Craig E. Palmer | SVP, U.S. SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2024 | 151 | 0 | - | - | Stock Option (right to buy) | |
| Craig E. Palmer | SVP, U.S. SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2024 | 404 | 0 | - | - | Stock Option (right to buy) | |
| Craig E. Palmer | SVP, U.S. SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 25 Mar 2024 | 379 | 674 | - | 0.2 | 90 | Common Stock |
| Craig E. Palmer | SVP, U.S. SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 25 Mar 2024 | 151 | 1,229 | - | 0.2 | 36 | Common Stock |
| Craig E. Palmer | SVP, U.S. SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 25 Mar 2024 | 404 | 1,078 | - | 0.2 | 96 | Common Stock |
| Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Feb 2024 | 1,650 | 805 | - | 0 | Common Stock | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 5,000 | 75,806 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.14 per share. | 20 Feb 2024 | 5,000 | 5,000 | - | 5.1 | 25,705 | Common Stock |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 20 Feb 2024 | 2,545 | 2,455 | - | 21.9 | 55,748 | Common Stock |
| Hykes Kevin | Director, PRES & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 360,000 | 360,000 | - | - | Stock Option (right to buy) | |
| E. Palmer Craig | SVP, U.S. SALES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 31,600 | 31,600 | - | - | Stock Option (right to buy) | |
| Verrastro Paul | CHIEF MKTG & STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Oasheim Jared | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 55,500 | 55,500 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 22,050 | 22,050 | - | - | Stock Option (right to buy) | |
| Yared Nadim | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 29 Jan 2024 | 4,055 | 24,310 | - | 0.2 | 961 | Common Stock |
| Nadim Yared | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 29 Jan 2024 | 1,945 | 26,255 | - | 0.2 | 461 | Common Stock |
| Nadim Yared | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 1,945 | 29,092 | - | - | Stock Option (right to buy) | |
| Yared Nadim | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 4,055 | 0 | - | - | Stock Option (right to buy) | |
| Slattery Joseph P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.18 per share. | 28 Dec 2023 | 174 | 22,049 | - | 1.2 | 206 | Common Stock |
| Joseph Slattery P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.96 per share. | 28 Dec 2023 | 96 | 22,145 | - | 4.0 | 380 | Common Stock |
| P. Joseph Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 1,456 | 0 | - | - | Stock Option (right to buy) | |
| Joseph Slattery P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 28 Dec 2023 | 224 | 20,419 | - | 0.2 | 53 | Common Stock |
| Joseph Slattery P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 174 | 0 | - | - | Stock Option (right to buy) | |
| P. Joseph Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 224 | 0 | - | - | Stock Option (right to buy) | |
| P. Joseph Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 28 Dec 2023 | 1,456 | 21,875 | - | 0.2 | 345 | Common Stock |
| Joseph Slattery P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 96 | 7,590 | - | - | Stock Option (right to buy) | |
| Ali Behbahani | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 14 Dec 2023 | 316 | 316 | - | 0.2 | 75 | Common Stock |
| Ali Behbahani | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 316 | 0 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 18.55 per share. | 03 Aug 2023 | 628 | 0 | - | 18.6 | 11,652 | Common Stock |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 17.49 per share. | 31 Jul 2023 | 1,122 | 2,628 | - | 17.5 | 19,629 | Common Stock |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 3,750 | 80,806 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Jul 2023 | 2,000 | 628 | - | 0 | Common Stock | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.14 per share. | 31 Jul 2023 | 3,750 | 3,750 | - | 5.1 | 19,279 | Common Stock |
| Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 12,012 | 12,012 | - | - | Stock Option (right to buy) | |
| Kevin Hykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 12,012 | 12,012 | - | - | Stock Option (right to buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 12,012 | 12,012 | - | - | Stock Option (right to buy) | |
| Mudit K. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 12,012 | 12,012 | - | - | Stock Option (right to buy) | |
| Kirk Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 12,012 | 12,012 | - | - | Stock Option (right to buy) | |
| Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 12,012 | 12,012 | - | - | Stock Option (right to buy) | |
| Craig E. Palmer | SVP, U.S. SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 16 May 2023 | 295 | 295 | - | 0.2 | 70 | Common Stock |
| Craig E. Palmer | SVP, U.S. SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2023 | 295 | 0 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Liz Galle | VP OF GLOBAL CLINICAL RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 26,000 | 26,000 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Craig E. Palmer | SVP, U.S. SALES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Jan 2023 | 7,080 | 20,255 | - | 0 | Common Stock | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 9,000 | 84,556 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Nov 2022 | 4,400 | 0 | - | 0 | Common Stock | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 28 Nov 2022 | 600 | 4,400 | - | 12.5 | 7,513 | Common Stock |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 11.85 per share. | 28 Nov 2022 | 4,000 | 5,000 | - | 11.9 | 47,418 | Common Stock |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.14 per share. | 28 Nov 2022 | 9,000 | 9,000 | - | 5.1 | 46,269 | Common Stock |
| Nadim Yared | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP OF REG. AFFAIRS AND QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Liz Galle | VP OF GLOBAL CLINICAL RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Craig E. Palmer | SVP, U.S. SALES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| John M. Nehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 26,985 | 26,985 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 26,985 | 26,985 | - | - | Stock Option (right to buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 26,985 | 26,985 | - | - | Stock Option (right to buy) | |
| Mudit K. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 26,985 | 26,985 | - | - | Stock Option (right to buy) | |
| Kirk Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 26,985 | 26,985 | - | - | Stock Option (right to buy) | |
| Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 26,985 | 26,985 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 02 Jun 2022 | 1,264 | 1,264 | - | 0.2 | 300 | Common Stock |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 2,633 | 527 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,160 | 0 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 2,528 | 0 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 1,264 | 0 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 02 Jun 2022 | 2,633 | 9,585 | - | 0.2 | 624 | Common Stock |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 02 Jun 2022 | 3,160 | 6,952 | - | 0.2 | 749 | Common Stock |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 02 Jun 2022 | 2,528 | 3,792 | - | 0.2 | 599 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 5.05 per share. | 24 May 2022 | 8,070 | 1,711,355 | - | 5.0 | 40,752 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 19 May 2022 | 4,432 | 1,703,285 | - | 5.0 | 22,336 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 19 May 2022 | 13,387 | 1,698,853 | - | 5.0 | 67,409 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 19 May 2022 | 10,976 | 1,685,466 | - | 5.0 | 55,297 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 5.99 per share. | 03 May 2022 | 25,503 | 1,670,498 | - | 6.0 | 152,760 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 03 May 2022 | 3,992 | 1,674,490 | - | 6.0 | 23,936 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 03 May 2022 | 32,809 | 1,644,995 | - | 6.0 | 196,762 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 5.97 per share. | 28 Apr 2022 | 41,988 | 1,612,186 | - | 6.0 | 250,673 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 5.97 per share. | 28 Apr 2022 | 100 | 1,570,198 | - | 6.0 | 597 | Common Stock |
| Nadim Yared | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 25 Apr 2022 | 6,059 | 27,335 | - | 0.2 | 1,436 | Common Stock |
| Nadim Yared | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 6,059 | 4,055 | - | - | Stock Option (right to buy) | |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 22 Apr 2022 | 1,264 | 21,901 | - | 0.2 | 300 | Common Stock |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 22 Apr 2022 | 3,792 | 20,637 | - | 0.2 | 899 | Common Stock |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 22 Apr 2022 | 2,221 | 16,845 | - | 0.2 | 526 | Common Stock |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 22 Apr 2022 | 1,590 | 12,040 | - | 0.2 | 377 | Common Stock |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 22 Apr 2022 | 2,584 | 14,624 | - | 0.2 | 612 | Common Stock |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 1,264 | 0 | - | - | Stock Option (right to buy) | |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 3,792 | 0 | - | - | Stock Option (right to buy) | |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 2,221 | 0 | - | - | Stock Option (right to buy) | |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 2,584 | 702 | - | - | Stock Option (right to buy) | |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 1,590 | 685 | - | - | Stock Option (right to buy) | |
| Mudit K. Jain | Director | Purchase of securities on an exchange or from another person at price $ 9.03 per share. | 28 Feb 2022 | 600 | 3,400 | - | 9.0 | 5,420 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 8.24 per share. | 24 Feb 2022 | 3,400 | 1,570,098 | - | 8.2 | 28,010 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 8.04 per share. | 18 Feb 2022 | 38,200 | 1,566,698 | - | 8.0 | 307,143 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 7.92 per share. | 18 Feb 2022 | 26,659 | 1,488,490 | - | 7.9 | 211,227 | Common Stock |
| Kirk Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 7.94 per share. | 18 Feb 2022 | 40,008 | 1,528,498 | - | 7.9 | 317,660 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 2,275 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 780 | 20,428 | - | 0.2 | 185 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 12,383 | 32,811 | - | 0.2 | 2,935 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 2,862 | 35,673 | - | 0.2 | 678 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 1,264 | 36,937 | - | 0.2 | 300 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 1,264 | 38,201 | - | 0.2 | 300 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 2,528 | 40,729 | - | 0.2 | 599 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 1,169 | 41,898 | - | 0.2 | 277 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 821 | 42,719 | - | 0.2 | 195 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 378 | 43,097 | - | 0.2 | 90 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 1,590 | 44,687 | - | 0.2 | 377 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 2,528 | 47,215 | - | 0.2 | 599 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 2,275 | 49,490 | - | 0.2 | 539 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 08 Feb 2022 | 5,158 | 54,648 | - | 0.2 | 1,222 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 780 | 315 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 12,383 | 4,128 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 2,862 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 1,264 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 1,264 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 2,528 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 1,169 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 821 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 378 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 1,590 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 2,528 | 0 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 5,158 | 2,048 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 03 Feb 2022 | 1,266 | 21,276 | - | 0.2 | 300 | Common Stock |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 03 Feb 2022 | 5,916 | 20,010 | - | 0.2 | 1,402 | Common Stock |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 03 Feb 2022 | 3,792 | 14,094 | - | 0.2 | 899 | Common Stock |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 03 Feb 2022 | 5,057 | 10,302 | - | 0.2 | 1,199 | Common Stock |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 03 Feb 2022 | 2,659 | 5,245 | - | 0.2 | 630 | Common Stock |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,266 | 11,375 | - | - | Common Stock | |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 5,916 | 0 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 3,792 | 0 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 5,057 | 0 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 2,659 | 0 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Jan 2022 | 10,500 | 2,586 | - | 0 | Common Stock | |
| Nadim Yared | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 186,400 | 186,400 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 56,200 | 56,200 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 23,600 | 23,600 | - | - | Stock Option (right to buy) | |
| Liz Galle | VP of Global Clinical Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 25,900 | 25,900 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 41,200 | 41,200 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 2,149 | 10,704 | - | 0.2 | 509 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 316 | 14,937 | - | 0.2 | 75 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 316 | 15,253 | - | 0.2 | 75 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 2,528 | 17,781 | - | 0.2 | 599 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 189 | 17,970 | - | 0.2 | 45 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 189 | 18,159 | - | 0.2 | 45 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 189 | 18,348 | - | 0.2 | 45 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 189 | 18,537 | - | 0.2 | 45 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 316 | 18,853 | - | 0.2 | 75 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 758 | 19,611 | - | 0.2 | 180 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 13 Jan 2022 | 584 | 20,195 | - | 1.2 | 693 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 2,149 | 224 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 3,917 | 1,456 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 316 | 0 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 2,528 | 0 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 316 | 0 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 584 | 174 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 758 | 0 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 316 | 0 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 189 | 0 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 189 | 0 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 189 | 0 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 13 Jan 2022 | 3,917 | 14,621 | - | 0.2 | 928 | Common Stock |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2022 | 189 | 0 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 28 Dec 2021 | 2,080 | 13,086 | - | 0.2 | 493 | Common Stock |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 2,080 | 2,659 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 3,000 | 2,373 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 30 Nov 2021 | 3,000 | 8,555 | - | 0.2 | 720 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 24 Nov 2021 | 14,000 | 19,648 | - | 0.2 | 3,360 | Common Stock |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2021 | 14,000 | 1,095 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 11,006 | 4,739 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 22 Nov 2021 | 11,006 | 11,006 | - | 0.2 | 2,641 | Common Stock |
| Mudit K. Jain | Director | Purchase of securities on an exchange or from another person at price $ 13.69 per share. | 18 Nov 2021 | 300 | 2,800 | - | 13.7 | 4,106 | Common Stock |
| Mudit K. Jain | Director | Purchase of securities on an exchange or from another person at price $ 14.63 per share. | 18 Nov 2021 | 875 | 2,500 | - | 14.6 | 12,804 | Common Stock |
| Mudit K. Jain | Director | Purchase of securities on an exchange or from another person at price $ 19.72 per share. | 12 Aug 2021 | 625 | 1,625 | - | 19.7 | 12,328 | Common Stock |
| Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2021 | 24,885 | 24,885 | - | - | Stock Option (right to buy) | |
| Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2021 | 9,988 | 9,988 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 18.00 per share. | 02 Jul 2021 | 5,555 | 5,555 | - | 18 | 99,990 | Common Stock |
| Geoff Pardo | Director | 02 Jul 2021 | 24,583,397 | 0 | - | - | Series G Preferred Stock | ||
| Geoff Pardo | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 02 Jul 2021 | 275,000 | 1,829,022 | - | 18 | 4,950,000 | Common Stock |
| Geoff Pardo | Director | 02 Jul 2021 | 1,554,022 | 1,554,022 | - | - | Common Stock | ||
| Kirk Nielsen | Director | 02 Jul 2021 | 1,461,831 | 1,461,831 | - | - | Common Stock | ||
| Kirk Nielsen | Director | 02 Jul 2021 | 23,125,000 | 0 | - | - | Series G Preferred Stock | ||
| John Brintnall | Chief Strategy Officer and Sec | 02 Jul 2021 | 89,518 | 0 | - | - | Series G-2 Preferred Stock | ||
| John Brintnall | Chief Strategy Officer and Sec | 02 Jul 2021 | 88,653 | 0 | - | - | Series F-2 Preferred Stock | ||
| John Brintnall | Chief Strategy Officer and Sec | 02 Jul 2021 | 5,658 | 7,900 | - | - | Common Stock | ||
| John Brintnall | Chief Strategy Officer and Sec | 02 Jul 2021 | 2,242 | 2,242 | - | - | Common Stock | ||
| Mudit K. Jain | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 01 Jul 2021 | 222,222 | 933,383 | - | 18 | 3,999,996 | Common Stock |
| Mudit K. Jain | Director | 01 Jul 2021 | 11,250,000 | 0 | - | - | Series G Preferred Stock | ||
| Mudit K. Jain | Director | Purchase of securities on an exchange or from another person at price $ 25.10 per share. | 01 Jul 2021 | 1,000 | 1,000 | - | 25.1 | 25,100 | Common Stock |
| Mudit K. Jain | Director | 01 Jul 2021 | 711,161 | 711,161 | - | - | Common Stock | ||
| John M. Nehra | Director | Purchase of securities on an exchange or from another person at price $ 25.80 per share. | 30 Jun 2021 | 50 | 100 | - | 25.8 | 1,290 | Common Stock |
| John M. Nehra | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 30 Jun 2021 | 27,777 | 28,266 | - | 18 | 499,986 | Common Stock |
| John M. Nehra | Director | Purchase of securities on an exchange or from another person at price $ 27.42 per share. | 30 Jun 2021 | 50 | 50 | - | 27.4 | 1,371 | Common Stock |
| John M. Nehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 9,100 | 9,100 | - | - | Stock Option (right to buy) | |
| John M. Nehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 10,382 | 10,382 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 10,382 | 10,382 | - | - | Stock Option (right to buy) | |
| Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 9,100 | 9,100 | - | - | Stock Option (right to buy) | |
| Nadim Yared | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 97,800 | 97,800 | - | - | Stock Option (right to buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 10,382 | 10,382 | - | - | Stock Option (right to buy) | |
| Mudit K. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 10,382 | 10,382 | - | - | Stock Option (right to buy) | |
| Geoff Pardo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 10,382 | 10,382 | - | - | Stock Option (right to buy) | |
| Kirk Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 10,382 | 10,382 | - | - | Stock Option (right to buy) | |
| Jared Oasheim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 36,700 | 36,700 | - | - | Stock Option (right to buy) | |
| John Brintnall | Chief Strategy Officer and Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 18,300 | 18,300 | - | - | Stock Option (right to buy) | |
| Dean Bruhn-Ding | VP of Reg. Affairs and QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 19,000 | 19,000 | - | - | Stock Option (right to buy) | |
| Liz Galle | VP of Global Clinical Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 19,700 | 19,700 | - | - | Stock Option (right to buy) | |
| Paul Verrastro | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 19,000 | 19,000 | - | - | Stock Option (right to buy) |